揭开心脏病患者和丹-卢药片治疗患者中错调的复杂生理过程
Ankur Datta1, Neethu George1, Tejaswini Koppolu1
1Laboratory of Integrative Genomics, Department of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu 632014, India.
Computational biology and chemistry
|July 30, 2024
概括
这项研究确定了冠心病 (CHD) 患者的关键基因表达模式. ARF6和STAT5B基因与髓状细胞亡和细胞调节有关,为向治疗提供了潜力.
科学领域:
- 心血管生物学 心血管生物学
- 生物信息学是一种生物信息学.
- 分子遗传学 分子遗传学
背景情况:
- 冠心病 (CHD) 是一个主要的全球健康问题,由动脉样硬化驱动,导致严重的心脏并发症.
- 有效的CHD管理需要了解其多因素性质,包括遗传倾向和治疗反应.
- 识别分子生物标志物对于开发针对性治疗心血管疾病的策略至关重要.
研究的目的:
- 通过分析基因表达特征来确定冠心病 (CHD) 的分子生物标志物.
- 为了研究丹路片治疗对心脏病患者基因表达的影响.
- 探索差异表达基因 (DEGs) 在心脏病发病过程中的功能作用.
主要方法:
- 利用GEO2R分析24个样本的基因表达数据:8个未经治疗的CHD,8个治疗的CHD和8个健康的对照.
- 采用生物信息学工具,如Cytoscape,MCODE,clusterProfiler和ClueGO,用于DEG的网络和功能分析.
- 在已识别的DEGs上进行了基因本体学 (GO) 和基因和基因组京都百科全书 (KEGG) 路径丰富分析.
主要成果:
- 在未接受治疗的CHD患者中鉴定了182个DEG,在接受治疗的CHD患者中鉴定了174个DEG.
- 发现ARF6基因失调与骨髓细胞亡和actin细胞骨架调节相关.
- 发现STAT5B基因差异性表达与髓状细胞亡和红细胞分化有关.
结论:
- ARF6和STAT5B是潜在的CHD分子生物标志物,参与关键的细胞过程.
- 基因表达特征分析可以揭示心脏病的治疗点.
- 基于个体基因表达特征的个性化医疗方法对未来的心血管疾病治疗充满希望.
相关概念视频
01:27Psychoneuroimmunology: Cardiovascular Disease
29
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
29
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:29Pathophysiology of Cardiac Performance
624
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
624
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69